Optimizing peptide nucleic acid-based pretargeting for enhanced targeted radionuclide therapy

Authors

Mohamed Altai, Lund University
Ábel Nagy, KTH Royal Institute of Technology
Pauline Granit, KTH Royal Institute of Technology
Wahed Zedan, Lund University
Myriam Cerezo-Magaña, Lund University
Julie Park, University of Caifornia
Katharina Lückerath, University of Duisburg-Essen
Susanne Geres, Lund University
Marie Sydoff, Lund University
Daniel L J Thorek, Washington University School of Medicine in St. Louis
Kristina Westerlund, KTH Royal Institute of Technology
David Ulmert, University of California
Amelie Eriksson Karlström, KTH Royal Institute of Technology

Journal

Journal of Controlled Release

Publication Date

5-10-2025

Volume

381

First Page

113551

Document Type

Open Access Publication

DOI

10.1016/j.jconrel.2025.02.047

Rights and Permissions

Altai M, Nagy Á, Granit P, Zedan W, Cerezo-Magaña M, Park J, Lückerath K, Geres S, Sydoff M, Thorek DLJ, Westerlund K, Ulmert D, Karlström AE. Optimizing peptide nucleic acid-based pretargeting for enhanced targeted radionuclide therapy. J Control Release. 2025 May 10;381:113551. doi: 10.1016/j.jconrel.2025.02.047 This is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Altai, Mohamed; Nagy, Ábel; Granit, Pauline; Zedan, Wahed; Cerezo-Magaña, Myriam; Park, Julie; Lückerath, Katharina; Geres, Susanne; Sydoff, Marie; Thorek, Daniel L J; Westerlund, Kristina; Ulmert, David; and Karlström, Amelie Eriksson, "Optimizing peptide nucleic acid-based pretargeting for enhanced targeted radionuclide therapy." Journal of Controlled Release. 381, 113551 (2025).
https://digitalcommons.wustl.edu/oa_4/5376

Additional Links

Supplemental material is available for this article at publisher site.